Hussein Awada

23PUBLICATIONS
75CO-AUTHORS
Predictive and prognostic markersRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Dec 03, 2025
DDX41-mutant myeloid neoplasms defy current prognostic schemes and require a dedicated risk scoring system: a multicenter, retrospective study.

Carmelo Gurnari, Hideki Makishima, Arda Durmaz

|Jan 29, 2025
Elderly Patients With Aplastic Anemia: Treatment Patterns and Outcomes in the Real World.

Bruno Fattizzo, Carmelo Gurnari, Sabrina Giammarco

|Oct 04, 2024
Synergistic effect of concurrent high molecular risk mutations and lower JAK2 mutant variant allele frequencies on prognosis in patients with myelofibrosis-insights from a multicenter study.

Yu-Hung Wang, Chao-Hung Wei, Chien-Chin Lin

|May 31, 2024
Impact of Extraosseous Extramedullary Disease on Outcomes of Patients with Relapsed-Refractory Multiple Myeloma receiving Standard-of-Care Chimeric Antigen Receptor T-Cell Therapy.

Danai Dima, Al-Ola Abdallah, James A Davis

|Apr 29, 2024
Clonal hematopoiesis-derived therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplant for lymphoid and non-lymphoid disorders.

Hussein Awada, Carmelo Gurnari, Valeria Visconte

|Feb 28, 2024
Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting.

Yasuo Kubota, Xiaorong Gu, Laila Terkawi

Pageof 4

Frequent Collaborators

10 joint publications

Jaroslaw P Maciejewski

10 joint publications

Carmelo Gurnari

9 joint publications

Valeria Visconte

4 joint publications

Faiz Anwer